goal was to evaluate progress 2000-2014 in cooperative group clinical trials of new agents for rhabdomyosarcoma. The students concluded that in such trials >525 patients had been planned, at a potential overall cost well exceeding $4.7M (not counting the expense of the drugs themselves). Many of the results of these clinical trials are still pending. That said, this was a very hardworking group of students who really came together for a high-level project and did a terrific job.
Unraveling rhabdomyosarcoma, osteosarcoma, dipg and medulloblastoma using engineering, biomedical, and translational research tools.
Showing posts with label community volunteer opportunity. Show all posts
Showing posts with label community volunteer opportunity. Show all posts
Friday, August 29, 2014
2014 Rhabdomyosarcoma Pico-course
It was an exciting week for the participants of the 2014 Rhabdomyosarcoma Pico-course. The
goal was to evaluate progress 2000-2014 in cooperative group clinical trials of new agents for rhabdomyosarcoma. The students concluded that in such trials >525 patients had been planned, at a potential overall cost well exceeding $4.7M (not counting the expense of the drugs themselves). Many of the results of these clinical trials are still pending. That said, this was a very hardworking group of students who really came together for a high-level project and did a terrific job.
goal was to evaluate progress 2000-2014 in cooperative group clinical trials of new agents for rhabdomyosarcoma. The students concluded that in such trials >525 patients had been planned, at a potential overall cost well exceeding $4.7M (not counting the expense of the drugs themselves). Many of the results of these clinical trials are still pending. That said, this was a very hardworking group of students who really came together for a high-level project and did a terrific job.
Thursday, January 16, 2014
Fishermen helping kids with cancer
This incredible group of commercial fishermen in British Columbia support children with cancer and childhood cancer research while having a fun time. Their website and 2013 herring sale video can be seen at www.fishermenhelpingkidswithcancer.com.
Wednesday, September 11, 2013
New & Improved: Patient & Family Wall
Saturday, August 10, 2013
2013 Rhabdomyosarcoma Pico-Course
We are grateful to the speakers and participants of the 2013 Rhabdomyosarcoma Pico-Course who critically evaluated the 'preclinical gap' in childhood cancer research. This pico-course had a decidedly sea-faring theme (some participants came from Fishermen helping kids with cancer). The conclusion? Acceleration of promising clinical trials is possible.
Wednesday, July 3, 2013
Megan discusses community partnering
Our rhabdomyosarcoma crowdfunding project at the Consano website is described here, and the Megan's short personal introduction can be seen in this video.
Sunday, April 7, 2013
crowdfunding !
Please consider participating in our first rhabdomyosarcoma crowdfunding project, "Halting Tumor cells from Spreading by Blocking Hostile Mergers". More details can be found on the Consano website (new url) here.
[ update 4/7/13: See the story behind the founding of the Consano crowdfunding site with Molly's interview Here. ]
[ update 4/7/13: See the story behind the founding of the Consano crowdfunding site with Molly's interview Here. ]
Sunday, September 16, 2012
2:1 matching dollars for alveolar rhabdomyosarcoma
A
pharmaceutical company in the Northeast has offered 2:1 matching dollars to
fund research on a kinase inhibitor they make which our lab believes will be of
benefit to patients with alveolar rhabdomyosarcoma. The pharmaceutical company is willing to contribute up to $84,000
to match donations from the community of up to $42,000.
This particular drug (kinase inhibitor) has a
good rationale for being important exclusively in the alveolar subtype of
rhabdomyosarcoma, and it is rare that we find a partner in industry willing to
advance a drug just for alveolar rhabdomyosarcoma to the clinic. The
basic science studies we would do (preclinical studies) are the prelude to
clinical trial studies that the pharmaceutical company would pay for in full
(usually a >$2M investment on their part).
For more information, please email Charles at keller@ohsu.edu .
Monday, August 13, 2012
Pediatric Cancer Nanocourse 2012
We are grateful and inspired by the 12 participants that came to Portland for the one-week Pediatric Cancer Nanocourse. The goal was to create science‐informed liaisons between childhood cancer researchers and the community in order to empower the public to drive the cure of rare cancers. We firmly believe liaisons like these dedicated individuals, many of whom experienced unthinkable loss, are needed to speed the development of new and effective childhood cancer treatments. We welcome the opportunity to work together with these individuals and the community in this shared mission.
[ update 1/31/2014: see details of the 2012 Nanocourse peer-reviewed publication. ]
Wednesday, February 8, 2012
Scientific Writer needed
We are looking for a volunteer technical writer from the community to co-author a scientific paper on childhood cancer research from results already compiled. This endeavor is an experiments of sorts to see whether we can begin to blend the community with academics to create a seamless and efficient way of moving towards new treatments for childhood cancers. If you have time and interest, please contact Charles at keller (at) ohsu.edu. with thanks, the Keller Lab team.
Tuesday, January 24, 2012
Graphics Volunteer Needed
We are hoping to work with a volunteer in the community with graphic arts/communication experience. The project is about 6 weeks long and may take 8-12 hours a week. If you have time and interest, please contact Charles at keller (at) ohsu.edu. with thanks, the Keller Lab team
Subscribe to:
Posts (Atom)





